Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
Communications Biology
|
June 20, 2023
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
Cecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, et al.
Neuro-Oncology
|
September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients
Ju-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type Glioblastoma
Rachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Neuro-Oncology
|
May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
Bianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
Communications Biology
|
June 20, 2023
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
Cecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, et al.
Neuro-Oncology
|
September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients
Ju-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type Glioblastoma
Rachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Neuro-Oncology
|
May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
Bianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Page
of 9